Research on Pei Zhengxue's Formulation Series

3.2 Effect of Pei’s Soft Liver and Anti-Bloating Pill on Tumor Inhibition Rate and Tumor Weight in Tumor-Bearing Mice

Chapter 380

### 3.2 Effect of Pei’s Soft Liver and Anti-Bloating Pill on Tumor Inhibition Rate and Tumor Weight in Tumor-Bearing Mice

From Research on Pei Zhengxue's Formulation Series · Read time 1 min · Updated March 22, 2026

Keywords方药研究, 实验研究, 配方资产, 转化沟通, 6.2.4 消风Ⅱ号胶囊对去肾上腺AA大鼠膝关节组织病理学变化的影响

Section Index

  1. 3.2 Effect of Pei’s Soft Liver and Anti-Bloating Pill on Tumor Inhibition Rate and Tumor Weight in Tumor-Bearing Mice

3.2 Effect of Pei’s Soft Liver and Anti-Bloating Pill on Tumor Inhibition Rate and Tumor Weight in Tumor-Bearing Mice

After dissection, it is found that the tumor in the treatment group grows more slowly than in the model group. The average tumor weights in the large, medium, and small dose groups of Pei’s Soft Liver and Anti-Bloating Pill are all lower than those in the model group, at (0.914±0.073) g, (0.777±0.084) g, and (0.966±0.079) g respectively, all of which are statistically significant compared with the model group (p<0.05). The corresponding tumor inhibition rates are 32.2%, 42.4%, and 28.2%. (See Table 1, Figure 1, and Figure 2)

Table 1: Effect of Pei’s Soft Liver and Anti-Bloating Pill on Tumor Weight in Tumor-Bearing Mice (x±s)

GroupDosage (g/kg)Number of MiceAverage Tumor Weight (g)Tumor Inhibition Rate (%)
Model Control Group-121.347±0.125-
PRGXP Small Dose Group1.0120.966±0.07928.2
PRGXP Medium Dose Group2.0120.777±0.08442.4
PRGXP Large Dose Group4.0120.914±0.07332.2
BM Group0.25120.928±0.07128.9

Note: *p<0.05, compared with the model control group

This chapter is prepared for online research and reading; for external materials, please align with original publications and the review process.